The polycystic ovary post-Rotterdam: A common, age-dependent finding in ovulatory women without metabolic significance

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 11, 2010, Pages 4965-4972

  Johnstone, Erica B ^a   Rosen, Mitchell P ^a   Neril, Rebecca ^a   Trevithick, Deborah ^a   Sternfeld, Barbara ^b   Murphy, Rosemary ^b   Addauan Andersen, Carolyne ^a   McConnell, Daniel ^c   Reijo Pera, Renee ^d   Cedars, Marcelle I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRONE; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ANOVULATION; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; ESTRONE BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY; WAIST CIRCUMFERENCE;

EID: 78049490321     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0202     Document Type: Article

References (43)

1. Balen AH, Laven JS, Tan SL, Dewailly D 2003 Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505-514 (Pubitemid 38072143)
2. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D 2003 Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 18:598-603
3. Pache TD, Wladimiroff JW, Hop WC, Fauser BC 1992 How to discriminate between normal and polycystic ovaries: transvaginal US study. Radiology 183:421-423
4. van Santbrink EJ, Hop WC, Fauser BC 1997 Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 67:452-458
5. Adams J, Polson DW, Franks S 1986 Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 293:355-359
6. Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S, Meade TW 1992 How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) 37:127-134
7. Polson DW, Adams J, Wadsworth J, Franks S 1988 Polycystic ovaries: a common finding in normal women. Lancet 1:870-872
8. Farquhar CM, Birdsall M, Manning P, Mitchell JM, France JT 1994 The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust NZ J Obstet Gynaecol 34:67-72
9. Abdel Gadir A, Khatim MS, Mowafi RS, Alnaser HM, Muharib NS, Shaw RW 1992 Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles. Hum Reprod 7:453-457
10. Michelmore KF, Balen AH, Dunger DB, Vessey MP 1999 Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 51:779-786
11. Koivunen R, Laatikainen T, Tomás C, Huhtaniemi I, Tapanainen J, Martikainen H 1999 The prevalence of polycystic ovaries in healthy women. Acta Obstet Gynecol Scand 78:137-141
12. Ruess ML, Kline J, Santos R, Levin B, Timor-Tritsch I 1996 Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol 174:624-627
13. Erdem A, Erdem M, Biberoglu K, Hayit O, Arslan M, Gursoy R 2002 Age-related changes in ovarian volume, antral follicle counts and basal FSH in women with normal reproductive health. J Reprod Med 47:835-839
14. Kline J, Kinney A, Kelly A, Reuss ML, Levin B 2005 Predictors of antral follicle count during the reproductive years. Hum Reprod 20:2179-2189
15. Huang FJ, Chang SY, Tsai MY, Kung FT, Wu JF, Chang HW 2001 Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation. J Assist Reprod Genet 18:91-96
16. Scheffer GJ, Broekmans FJ, Looman CW, Blankenstein M, Fauser BC, teJong FH, teVelde ER 2003 The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 18:700-706
17. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS 2005 Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.Hum Reprod 20:1820-1826
18. Duijkers IJ, Klipping C 2010 Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women. Gynecol Endocrinol 26:152-160
19. Shroff R, Kerchner A, Maifeld M, Van Beek EJ, Jagasia D, Dokras A 2007 Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab 92:4609-4614
20. Marcondes JA, Hayashida SA, Barcellos CR, Rocha MP, Maciel GA, Baracat EC 2007 Metabolic syndrome in women with polycystic ovary syndrome: prevalence, characteristics and predictors. Arq Bras Endocrinol Metabol 51:972-979
21. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN 2006 Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:48-53 (Pubitemid 43069116)
22. Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L 2003 Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 52:908-915
23. Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A 2005 Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 90:2571-2579 (Pubitemid 40686293)
24. Norman RJ, Hague WM, Masters SC, Wang XJ 1995 Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod 10:2258-2261
25. Carmina E, Wong L, Chang L, Paulson RJ, Sauer MV, Stanczyk FZ, Lobo RA 1997 Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum Reprod 12:905-909
26. Chang PL, Lindheim SR, Lowre C, Ferin M, Gonzalez F, Berglund L, Carmina E, Sauer MV, Lobo RA 2000 Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab 85:995-1000
27. Adams JM, Taylor AE, Crowley Jr WF, Hall JE 2004 Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 89:4343-4350
28. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC 2006 PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 113:1210-1217
29. Gordon NP 2006 How does the adult Kaiser Permanente membership in Northern California compare with the larger community? Oakland, CA: Kaiser Permanente Division of Research
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
31. Södergård R, Bäckström T, Shanbhag V, Carstensen H 1982 Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem 16:801-810
32. Murphy MK, Hall JE, Adams JM, Lee H, Welt CK 2006 Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome. J Clin Endocrinol Metab 91:3878-3884
33. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP 2004 Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10:77-83
34. Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN 2008 The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod 23:952-957
35. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC 2004 Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89:318-323
36. Su HI, Sammel MD, Freeman EW, Lin H, DeBlasis T, Gracia CR 2008 Body size affects measures of ovarian reserve in late reproductive age women. Menopause 15:857-861
37. Pigny P, Jonard S, Robert Y, Dewailly D 2006 Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91:941-945 (Pubitemid 43357762)
38. Mortensen M, Rosenfield RL, Littlejohn E 2006 Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab 91:3786-3790
39. Ng EH, Chan CC, Ho PC 2006 Are there differences in ultrasound parameters between Chinese women with polycystic ovaries only and with polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 125:92-98
40. Dewailly D, Catteau-Jonard S, Reyss AC, Maunoury-Lefebvre C, Poncelet E, Pigny P 2007 The excess in 2-5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome. Hum Reprod 22:1562-1566
41. Rizzo M, Berneis K, Hersberger M, Pepe I, Di Fede G, Rini GB, Spinas GA, Carmina E 2009 Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum Reprod 24:2286-2292
42. Moran L, Teede H 2009 Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update 15:477-488
43. Bili H, Laven J, Imani B, Eijkemans MJ, Fauser BC 2001 Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertilewomenof reproductive years. Eur J Endocrinol 145:749-755